This trial will give cannabidiol to people to see if it is effective and safe.
1 Primary · 3 Secondary · Reporting Duration: Day 1, 2, 7, 14, and 21
Experimental Treatment
120 Total Participants · 3 Treatment Groups
Primary Treatment: THC · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Age 18 - 55 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Maryland | 100.0% |
18 - 65 | 100.0% |
Johns Hopkins University | 100.0% |
Met criteria | 100.0% |